Correlation Between Connect Biopharma and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Bristol Myers Squibb, you can compare the effects of market volatilities on Connect Biopharma and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Bristol Myers.

Diversification Opportunities for Connect Biopharma and Bristol Myers

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Connect and Bristol is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Bristol Myers go up and down completely randomly.

Pair Corralation between Connect Biopharma and Bristol Myers

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 4.79 times more return on investment than Bristol Myers. However, Connect Biopharma is 4.79 times more volatile than Bristol Myers Squibb. It trades about 0.04 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.02 per unit of risk. If you would invest  86.00  in Connect Biopharma Holdings on September 3, 2024 and sell it today you would earn a total of  20.00  from holding Connect Biopharma Holdings or generate 23.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Connect Biopharma and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and Bristol Myers

The main advantage of trading using opposite Connect Biopharma and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Connect Biopharma Holdings and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum